MPD: Project measures / variables set: Wiltshire3 ACTH

ID, description, units	MPD:38101 ACTH cerebral cortex ACTH, relative fluorescence intensity fluoxetine study
Measures	• control • fluoxetine • change index
Data set, strains	Wiltshire3 inbred 30 strains sex: m age: 10-11wks
Procedure	biomarker quantification
Comparison	control group vs. treated group
Availability note:	Individual animal data were not submitted. Some functionality not available.
Ontology mappings	VT:0010120 protein amount VT:0010487 response to xenobiotic stimulus trait VT:0015058 brain physiology trait MA:0000168 brain MP:0008469 abnormal protein level MP:0008872 abnormal physiological response to xenobiotic

Project	ID		Treatment	Measure / Variable Description	Panel	Strains tested	Sex	Age
Wiltshire3	38101	biomarker quantification	fluoxetine	cerebral cortex ACTH, relative fluorescence intensity control ACTH_cont	inbred	30	m	10-11wks
Wiltshire3	38102	biomarker quantification	fluoxetine	cerebral cortex ACTH, relative fluorescence intensity fluoxetine ACTH_fluox	inbred	30	m	10-11wks
Wiltshire3	38103	biomarker quantification	fluoxetine	cerebral cortex ACTH, relative fluorescence intensity change index ACTH_index	inbred	30	m	10-11wks	(supplemental / summary measure)